Introduction Metabolic syndrome (MetS) is a cluster of pathological conditions well described in humans but still investigated insufficiently in animals. A novel approach in its management is the utilisation of nutrients from natural sources. Recent studies suggested that phenolic compounds from pomegranate peel could be a promising dietary intervention for MetS. This study evaluated the potency of polyphenol-rich pomegranate peel extract (EPP) in mitigating some MetS components in an animal model. Material and Methods Zucker diabetic fatty rats (with an fa/fa missense mutation in the Lepr leptin receptor gene) and their healthy counterparts (fa/+) as controls were fed a high-calorie diet to induce MetS and supplemented with EPP at two doses: 100 mg/kg body weight (b.w.) and 200 mg/kg b.w. The extract was administered for eight weeks. The rats’ body weights were monitored twice per week, and blood samples were taken before EPP administration after four weeks and eight weeks of study. Echocardiography measurement was performed at the beginning and at the end of the study. Results The extract restrained the dynamic of weight gain. A cardioprotective effect of the highest dose of EPP supplementation was manifested in a relative decrease in heart rate and improved mid-fractional shortening, representing myocardial contractility. No improvement in fasting blood glucose or lipid profile was observed. Conclusion Pomegranate peel extract possesses beneficial health properties that could be useful in dietary intervention in MetS. However, its bioavailability still requires further investigation in clinical trials in humans and animals suffering from endocrine and metabolic disorders.
The aim of this study was to determine whether the serum concentration of the phosphate (P i ) and the Ca x P value correlate with the IRIS stage of chronic kidney disease (CKD) in cats and, thus, whether they can be used as markers of the disease progression. Another aim was to assess whether the concentration of Ca in blood needs to be corrected based on the albumin concentration. The study was performed on 165 cats divided into five groups: the healthy group -C and study groups: I, II, III and IV with cats assigned to the groups based on the IRIS scale. Blood was collected from all the animals. The product of Ca x P i , Ca corr and the product of Ca corr x P i were calculated based on the obtained results. Despite no differences between groups I-III, there was a clear upward trend in the P i concentration, in the Ca x P i and in the Ca corr x P i with CKD progression. In group IV, the P i concentration and the Ca x P i as well as the Ca corr x P i value were significantly higher than the other groups. The concentration of Ca and its albumin-corrected serum values did not differ significantly. The serum concentration of P i and the Ca x P product cannot be used as indicators of CKD progression in cats, but they may be used as additional elements in the diagnosis of stage IV CKD. The results also suggest that the serum calcium concentrations do not need to be albumin-corrected in cats.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.